Home
About Us
There's a new contender in the fight against opioid addiction, and it's all thanks to some cutting-edge technology out of the University of Utah.
The Salt Lake Tribune reports three new life-science companies have received $700 million in funding from the Utah Innovation Fund, a state-backed venture capital fund.
The companies are 3Helix, Rebel Medicine, and Inherent Biosciences.
The money will be used to develop treatments for a variety of diseases, including arthritis, skin aging, auto-immunity, and fibrosis, caused by damage to collagen, the body's most abundant protein.
"If cells are cars, most therapies focus on pressing the gas or the brake; for the first time, we can change the signs on the road," says 3Helix VP Toby Barrack.
One of the new treatments, called bioACTIVE CHPs, binds to damaged collagen and brings with it signals and binding sites that fold into the native environment, allowing cells to respond to their environment appropriately.
"Tests have shown that CHPs are able to achieve several times the response of today's best therapies," says Barrack.
Another new treatment, Alevatrix, is a non-opioid anesthetic that lasts up to four days after surgery,
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Coral Vita: Over $8 million Series A Raised For Scaling Reef Restoration.Coral reefs support 25% of marine life and generate about $2.7 trillion annually.coral reefs face dire threats from climate...more
Community Impact Investing: Evaluating Nonprofits and Corporate Grants as Strategic Opportunities.In an era where ESG investing is reshaping capital markets, corporate philanthropy has emerged as a...more
Climate tech startups and investors have weathered a reality of rising interest rates, constrained capital markets, and geopolitical headwinds.This session will unpack the current state of early...more
California must consider how to increase interest in teaching and lower the cost of and barriers to entering the profession.AB-1128, a bill under consideration in the legislature, proposes a...more
Mondelēz's Sustainable Futures Impact Investment platform said the capital "further advance[s] scalable, high-impact solutions at the nexus of climate, community, and circularity" The companies...more
South African recycling startup Regenize has secured an undisclosed investment from E Squared Investments.The deal combines philanthropic goals with venture capital methods to support scalable,...more
Cambridge-based Remedium was named winner of the Climate Impact Prize at the Net Zero Technology Centre's annual TechX Demo Day in Aberdeen.The prize is given to the startup with the most promising...more
Sustainable Times is a media partner for this event, which takes place on June 24-25, 2025, at ExCeL London, as part of London Climate Action Week.RESET Connect provides a network of potential...more
Rad AI announces an additional $8 million investment led by four health systems.Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System lead the investment.Rad AI...more
MedTech CellCentric has raised 90m in fresh funding.The money will support the advancement of the Cambridge company's oral treatment for multiple myeloma, inobrodib.The financing was co-led by RA...more
Impact Investing News from...
Weingart Foundation
Venture Philanthropy Partners
Rockefeller Foundation
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
